Sick Economics. Healthcare Investing Tips & Analysis. Big Pharma, Biotech, Medical Devices, Healthcare REITs & More.
FEATURED ARTICLE:
SICK PICKS
Our favorite biotech shares and healthcare investments in today’s stock market. Highlighting companies that stand to profit through medical innovation, mismatches in share price to market potential, or just plain great economics. (Stocks may be owned by the Sick Economist, or other commentators on this page.)
ADMA
This microcap recently acquired a manufacturing facility to ensure better quality control of its formulations for patients with immune deficiencies. After successfully addressing manufacturing issues at the new plant, ADMA is ready to refile its lead drug application with the FDA. The result should be a fully integrated R&D and manufacturing company that helps patients suffering from immune related diseases.
SRTS
This small company patents, manufactures and sells capital equipment that dermatologists use to treat skin cancer and challenging aesthetic conditions. The company presents its radiation machines as a more appealing alternative to traditional skin surgeries. With the number of skin cancer cases set to explode over the coming decades, Sensus Inc is only beginning to address a rapidly growing market.
CHRS
Coherus Bioscience seeks to provide more affordable alternatives to some of the world’s most expensive biological treatments. After many years of research and development, Coherus is slowly approaching the point of being able to offer biosimilar products; FDA approved copies of some of the most critical, and costliest, treatments in modern medicine. The market potential is vast and rapidly growing.
